Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-05 · accession 0001493152-24-043707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-05 | BIAF | Edwards James Michael | VP, CFO | A - Grant | $0.00 | +100.0K | 114.0K | +717% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-05 | A | A | 100,000 | $0.00 | 113,956 | D | — | — | (F1) Grant of restricted shares, which shares will vest 25% on each of (1) the grant date, (2) the one year anniversary of the grant date, (3) the two year anniversary of the grant date and (4) the three year anniversary of the grant date. |